Pyrazinamide blood concentrations in children suffering from tuberculosis: a comparative study at two doses.
暂无分享,去创建一个
G. Sethi | V. Roy | Pooja Gupta | T. Mishra
[1] J. Grosset,et al. Pharmacokinetic and Pharmacodynamic Issues in the Treatment of Mycobacterial Infections , 2004, European Journal of Clinical Microbiology and Infectious Diseases.
[2] J. Cleveland,et al. Guidelines for infection control in dental health-care settings--2003. , 2003, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[3] O. Lafont,et al. Pharmacokinetics of pyrazinamide and its metabolites in healthy subjects , 2004, European Journal of Clinical Pharmacology.
[4] W. Burman,et al. Population Pharmacokinetic Modeling of Pyrazinamide in Children and Adults with Tuberculosis , 2002, Pharmacotherapy.
[5] C. Peloquin. Pharmacological Issues in the Treatment of Tuberculosis , 2001, Annals of the New York Academy of Sciences.
[6] S. Conroy,et al. Drug trials in children: problems and the way forward. , 2000, British journal of clinical pharmacology.
[7] V. Roy,et al. Pharmacokinetics of pyrazinamide in children suffering from pulmonary tuberculosis. , 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[8] D. Pessayre,et al. Hepatotoxicity of Antitubercular Treatments , 1996, Drug safety.
[9] M. Salfinger,et al. Determination of pyrazinamide MICs for Mycobacterium tuberculosis at different pHs by the radiometric method , 1988, Antimicrobial Agents and Chemotherapy.
[10] D. Mitchison,et al. Observations in vitro on the suitability of pyrazinamide for intermittent chemotherapy of tuberculosis. , 1970, Tubercle.
[11] G. Ellard. Absorption, metabolism and excretion of pyrazinamide in man. , 1969, Tubercle.
[12] S. P. Tripathy,et al. Concentrations of pyrazinamide attained in serum with different doses of the drug. , 1968, Bulletin of the World Health Organization.
[13] W. Mcdermott,et al. Activation of pyrazinamide and nicotinamide in acidic environments in vitro. , 1954, American review of tuberculosis.